A new study published in the International Journal of Drug Policy suggests chronic pain and mental health patients prefer cannabis to opioids. In the study, researchers surveyed 250 patients, of which 63% used cannabis in place of opioids, sedatives, and antidepressants. Patients who substituted cannabis for opioids and benzodiazepines, which were the two primary classes of drugs that were substituted, cited fewer side-effects, better symptom management, and a better safety profile as their top reasons for making the swap. This study has huge implications when it comes to battling the opioid epidemic that is sweeping the nation today. With fewer side effects and a higher safety profile, patients can feel more in control of effectively managing their symptoms without risking adverse side effects or overdose.
This information has been provided by the Medicinal Marijuana Association and approved by our Chief Medical Officer.